Abstract
We recently addressed the challenges of the German Health Care System (GHCS) in an era of an aging population and economic problems discussing the funding process, hospital management and ambulatory care, with a focus on cost control mechanisms and quality improvement measures. Pharmaceutical issues have not been mentioned in detail. It is of interest that increases in Social Health Insurance (SHI) expenditures on pharmaceuticals in Germany were above the European average in the last decades. There are three main aspects to consider when it comes to discussing the topic of pharmaceuticals in health care services, the efficacy of the drugs, safety issues and cost containment. The paper summarizes pharmaceutical issues as challenges for the German Health Care System.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
